| Product Code: ETC13134153 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Peripheral Arterial Disease Market was valued at USD 4.8 Billion in 2024 and is expected to reach USD 7.2 Billion by 2031, growing at a compound annual growth rate of 6.00% during the forecast period (2025-2031).
The Global Peripheral Arterial Disease (PAD) market is experiencing steady growth driven by the increasing prevalence of cardiovascular diseases, rising geriatric population, and lifestyle factors such as smoking and poor diet. Technological advancements in minimally invasive procedures, like angioplasty and stenting, are also contributing to market expansion. The market includes diagnostic tools, medications, and surgical interventions aimed at managing PAD and preventing associated complications such as limb amputations. Key players in the market are investing in research and development to introduce innovative treatment options and improve patient outcomes. Geographically, North America dominates the market due to high healthcare spending and awareness, while the Asia-Pacific region is expected to witness significant growth due to improving healthcare infrastructure and rising healthcare expenditure.
The Global Peripheral Arterial Disease (PAD) market is experiencing a surge in innovation and technological advancements, particularly in minimally invasive treatment options such as drug-coated balloons and stents. There is a growing emphasis on early diagnosis and management of PAD to prevent complications and improve patient outcomes. The market is also witnessing an increasing focus on personalized medicine and targeted therapies for better efficacy. Opportunities exist for companies to develop novel diagnostic tools and therapeutic interventions that cater to the specific needs of PAD patients. With the rising prevalence of PAD due to lifestyle changes and aging populations, the market is poised for significant growth in the coming years, presenting a promising landscape for investment and expansion.
The Global Peripheral Arterial Disease (PAD) market faces several challenges, including limited awareness among patients and healthcare providers leading to underdiagnosis and undertreatment of the disease. Additionally, the high cost of treatment options such as revascularization procedures and peripheral stents can be a barrier to access for some patients. Moreover, the competitive landscape with multiple companies offering similar products and the lack of standardized guidelines for PAD management pose challenges for market growth. Furthermore, the increasing prevalence of risk factors such as diabetes and obesity contributing to the rising incidence of PAD adds complexity to the market dynamics. Overall, addressing these challenges will require collaboration among stakeholders to improve disease awareness, ensure affordability of treatments, and develop comprehensive management strategies for PAD.
The Global Peripheral Arterial Disease (PAD) market is primarily driven by the increasing prevalence of cardiovascular diseases, diabetes, and obesity, which are major risk factors for developing PAD. Additionally, the aging population worldwide is contributing to the rising number of PAD cases, as the condition is more common in older individuals. Technological advancements in diagnostic tools and treatment options are also driving market growth, leading to improved outcomes and better patient management. Furthermore, the growing awareness among both patients and healthcare providers about the importance of early detection and treatment of PAD is fueling market expansion. Overall, the combination of these factors is expected to continue driving the growth of the Global PAD market in the coming years.
Government policies related to the Global Peripheral Arterial Disease (PAD) Market primarily focus on promoting awareness, improving access to healthcare services, and encouraging research and development in the field. Governments around the world have implemented initiatives to educate the public about PAD risk factors, symptoms, and treatment options. Additionally, policymakers have introduced measures to enhance early detection and diagnosis of PAD, as well as to ensure that patients have access to appropriate medical interventions. Furthermore, government funding and support for research projects aimed at advancing PAD treatment strategies, such as innovative therapies and medical devices, play a crucial role in driving market growth and improving patient outcomes in the PAD sector.
The Global Peripheral Arterial Disease (PAD) market is expected to witness significant growth in the coming years due to the increasing prevalence of PAD, especially in aging populations. Technological advancements in diagnostic tools and treatment options, such as minimally invasive procedures and drug-eluting stents, are likely to drive market expansion. Additionally, rising awareness about the importance of early detection and management of PAD is projected to further boost market growth. The market is also anticipated to benefit from the growing adoption of endovascular treatments and the development of novel therapies. However, challenges such as high treatment costs and limited access to advanced healthcare facilities in developing regions may hinder market growth to some extent. Overall, the Global PAD market is poised for expansion with opportunities for innovation and improved patient outcomes.
In the Global Peripheral Arterial Disease (PAD) market, Asia is expected to witness significant growth due to the rising prevalence of PAD in countries like China and India. North America holds a prominent market share, driven by advanced healthcare infrastructure and increasing awareness about PAD. In Europe, the market is characterized by a high adoption rate of advanced treatment options and favorable reimbursement policies. The Middle East and Africa region is experiencing gradual growth in the PAD market, attributed to improving healthcare facilities and a growing elderly population. Latin America is also showing promising growth opportunities, supported by increasing healthcare expenditure and a rising incidence of lifestyle-related diseases contributing to PAD. Overall, the global PAD market is projected to expand across all regions, driven by technological advancements and a growing patient population.
Global Peripheral Arterial Disease Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Peripheral Arterial Disease Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Peripheral Arterial Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Global Peripheral Arterial Disease Market - Industry Life Cycle |
3.4 Global Peripheral Arterial Disease Market - Porter's Five Forces |
3.5 Global Peripheral Arterial Disease Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Peripheral Arterial Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Global Peripheral Arterial Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Peripheral Arterial Disease Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Global Peripheral Arterial Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Peripheral Arterial Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Peripheral Arterial Disease Market Trends |
6 Global Peripheral Arterial Disease Market, 2021 - 2031 |
6.1 Global Peripheral Arterial Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Peripheral Arterial Disease Market, Revenues & Volume, By Devices, 2021 - 2031 |
6.1.3 Global Peripheral Arterial Disease Market, Revenues & Volume, By Catheters, 2021 - 2031 |
6.1.4 Global Peripheral Arterial Disease Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.1.5 Global Peripheral Arterial Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Peripheral Arterial Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Peripheral Arterial Disease Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Peripheral Arterial Disease Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.2.4 Global Peripheral Arterial Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Peripheral Arterial Disease Market, Revenues & Volume, By End Users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Peripheral Arterial Disease Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Peripheral Arterial Disease Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.4 Global Peripheral Arterial Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Peripheral Arterial Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Peripheral Arterial Disease Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.4.3 Global Peripheral Arterial Disease Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.4.4 Global Peripheral Arterial Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Peripheral Arterial Disease Market, Overview & Analysis |
7.1 North America Peripheral Arterial Disease Market Revenues & Volume, 2021 - 2031 |
7.2 North America Peripheral Arterial Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Peripheral Arterial Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4 North America Peripheral Arterial Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Peripheral Arterial Disease Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.6 North America Peripheral Arterial Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Peripheral Arterial Disease Market, Overview & Analysis |
8.1 Latin America (LATAM) Peripheral Arterial Disease Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Peripheral Arterial Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Peripheral Arterial Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
8.4 Latin America (LATAM) Peripheral Arterial Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Peripheral Arterial Disease Market, Revenues & Volume, By End Users, 2021 - 2031 |
8.6 Latin America (LATAM) Peripheral Arterial Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Peripheral Arterial Disease Market, Overview & Analysis |
9.1 Asia Peripheral Arterial Disease Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Peripheral Arterial Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Peripheral Arterial Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
9.4 Asia Peripheral Arterial Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Peripheral Arterial Disease Market, Revenues & Volume, By End Users, 2021 - 2031 |
9.6 Asia Peripheral Arterial Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Peripheral Arterial Disease Market, Overview & Analysis |
10.1 Africa Peripheral Arterial Disease Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Peripheral Arterial Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Peripheral Arterial Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
10.4 Africa Peripheral Arterial Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Peripheral Arterial Disease Market, Revenues & Volume, By End Users, 2021 - 2031 |
10.6 Africa Peripheral Arterial Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Peripheral Arterial Disease Market, Overview & Analysis |
11.1 Europe Peripheral Arterial Disease Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Peripheral Arterial Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Peripheral Arterial Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
11.4 Europe Peripheral Arterial Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Peripheral Arterial Disease Market, Revenues & Volume, By End Users, 2021 - 2031 |
11.6 Europe Peripheral Arterial Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Peripheral Arterial Disease Market, Overview & Analysis |
12.1 Middle East Peripheral Arterial Disease Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Peripheral Arterial Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Peripheral Arterial Disease Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Peripheral Arterial Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
12.4 Middle East Peripheral Arterial Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Peripheral Arterial Disease Market, Revenues & Volume, By End Users, 2021 - 2031 |
12.6 Middle East Peripheral Arterial Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Peripheral Arterial Disease Market Key Performance Indicators |
14 Global Peripheral Arterial Disease Market - Export/Import By Countries Assessment |
15 Global Peripheral Arterial Disease Market - Opportunity Assessment |
15.1 Global Peripheral Arterial Disease Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Peripheral Arterial Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
15.3 Global Peripheral Arterial Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Peripheral Arterial Disease Market Opportunity Assessment, By End Users, 2021 & 2031F |
15.5 Global Peripheral Arterial Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Peripheral Arterial Disease Market - Competitive Landscape |
16.1 Global Peripheral Arterial Disease Market Revenue Share, By Companies, 2024 |
16.2 Global Peripheral Arterial Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |